Zhang W, Wang Y, Tang Q, Li Z, et al. PAX2 mediated upregulation of ESPL1 contributes to cisplatin resistance in bladder cancer through activating the JAK2/STAT3 pathway. Naunyn Schmiedebergs Arch Pharmacol 2024 Apr 4. doi: 10.1007/s00210-024-03061.
PMID: 38573552